Literature DB >> 32683208

HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition.

Qi Wang1, Xuefei Li2, Shengxiang Ren1, Chunxia Su1, Chunyu Li3, Wei Li1, Jia Yu1, Ningning Cheng4, Caicun Zhou5.   

Abstract

OBJECTIVE: Previous research found that HOTAIR, a long non-coding RNA, is aberrantly expressed and associated with tumor invasion, metastasis and chemo-resistance in many cancers. The aim of this study was to investigate the role of HOTAIR in resistance of EGFR-TKIs in NSCLC.
METHODS: HOTAIR expression level was detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR) in NSCLC cell lines or tumor tissues. A total of 62 samples with EGFR-mutant and EGFR-TKI-sensitive NSCLCs, 42 with acquired resistance and 27 with primary resistance to EGFR-TKIs were analyzed. The effect of HOTAIR on cell proliferation and apoptosis was undergone by CCK-8 and flow cytometry assays. The expression of EMT proteins was assessed by western blot.
RESULTS: HOTAIR was significantly down-regulated in lung cancer cells (PC9/R, H1975, H1299 and A549) and patients with primary and acquired resistance to EGFR-TKIs. In clinical setting, high levels of HOTAIR expression was significantly correlated with longer progression-free survival (PFS) [P < 0.01] compared with low HOTAIR expression subgroup in tumors which respond to EGFR-TKIs. In vitro, over-expression HOTAIR could restore gefitinib sensitivity in gefitinib-resistant cells (PC9/R, H1299 and A549), but this change in sensitivity was not observed in H1975. Up-regulated HOTAIR induced cell apoptosis in PC9/R, H1299 and A549, and activated epithelial-mesenchymal transition (EMT).
CONCLUSIONS: HOTAIR expression was associated with primary and acquired resistance to EGFR-TKIs and could regulate cell proliferation through activating cell apoptosis and EMT, which suggest that HOTAIR might be able to act as a biomarker to predict the EGFR-TKIs resistance.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug resistance; EGFR-TKIs; Epithelial-mesenchymal transition; HOTAIR; Non-small cell lung cancer

Mesh:

Substances:

Year:  2020        PMID: 32683208     DOI: 10.1016/j.lungcan.2020.06.037

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

Review 1.  MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Authors:  Chao-Ju Chen; Yu-Peng Liu
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-06

2.  LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1.

Authors:  Yankang Li; Yue Shen; Mengyu Xie; Bowen Wang; Teng Wang; Jiajia Zeng; Hui Hua; Jinming Yu; Ming Yang
Journal:  Signal Transduct Target Ther       Date:  2022-01-31

Review 3.  Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance.

Authors:  Chunming Zhu; Xia Wang; Yuan Wang; Kefeng Wang
Journal:  Cell Death Discov       Date:  2022-09-13

Review 4.  Research progress regarding long-chain non-coding RNA in lung cancer: a narrative review.

Authors:  Ping Yu; Xuan He; Fei Lu; Ling Li; Huahua Song; Xiaolan Bian
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.